OncoHost Receives New York State Laboratory Permit for Precision Oncology Test
The permit enables the company to offer its PROphetNSCLC test to physicians and patients across New York State, completing nationwide availability.
The permit enables the company to offer its PROphetNSCLC test to physicians and patients across New York State, completing nationwide availability.
Teams complete whole human genome sequencing and analysis in under four hours, demonstrating potential for same-day NICU workflows.
With 70% of medical decisions depending on blood testing, experts highlight the toll of missed testing and the promise of alternative collection methods.
New TheraPEAK products include mammalian-derived cytokines for immune cell expansion and chemically defined medium for AAV production.
Findings show that early symptom patterns and biomarker data may help forecast which mild traumatic brain injury patients will experience 30-day symptom persistence.